Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Neoplasms 4 Colorectal Neoplasms 4 Head and Neck Neoplasms 2 Diabetes Mellitus 2 Chronic Disease 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Multiple Myeloma 1 Mucositis 1 Motor Activity 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lymphedema 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hypertension 1 Coronary Disease 1 Cardiovascular Diseases 1

Interventions

Zoledronic Acid 2 Vincristine 2 Temozolomide 2 Radiosurgery 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Doxorubicin 2 Cyclophosphamide 2 selinexor 1 saracatinib 1 samarium Sm-153 lexidronam 1 robatumumab 1 pembrolizumab 1 pegfilgrastim 1 angiotensin I (1-7) 1 Transcranial Direct Current Stimulation 1 Tranexamic Acid 1 Sunitinib 1 Standard of Care 1 Sodium Pertechnetate Tc 99m 1 Sodium Chloride 1 Samarium 1 Radiation 1 Proton Therapy 1 Pregabalin 1 Practice Guidelines as Topic 1 Plicamycin 1 Palliative Care 1 Nivolumab 1 Neutrons 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Bone Neoplasms × Methods × Clear all

NCT03963531 2025-12-10

METABONE

Institut Bergonié

545 enrolled 7 charts

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡